These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 6343146

  • 1. Immune complexes in pemphigus and bullous pemphigoid.
    Ahmed AR, Moy RL, Chia D, Barnett EV.
    Dermatologica; 1983; 166(4):175-80. PubMed ID: 6343146
    [Abstract] [Full Text] [Related]

  • 2. Serum and blister fluid immune complexes in bullous pemphigoid: detection with C1q and monoclonal rheumatoid factor.
    Jordon RE, Struve MF, Bushkell LL.
    Clin Exp Immunol; 1981 Jul; 45(1):29-36. PubMed ID: 7030538
    [Abstract] [Full Text] [Related]

  • 3. Comparison of IgG subclasses and complement binding activity of autoantibodies from patients with bullous pemphigoid and pemphigus.
    Brooks WS, Lee YY, Abell E, Deng JS.
    J Clin Lab Anal; 1989 Jul; 3(5):307-11. PubMed ID: 2681622
    [Abstract] [Full Text] [Related]

  • 4. Serum and blister fluid anticomplementary activity in pemphigus and bullous pemphigoid. Sucrose density gradient studies.
    Jordon RE, McDuffie FC.
    Proc Soc Exp Biol Med; 1976 Mar; 151(3):594-8. PubMed ID: 768993
    [Abstract] [Full Text] [Related]

  • 5. Bullous pemphigoid: a correlative study of autoantibodies, circulating immune complexes and dermo-epidermal deposits.
    Gomes MA, Dambuyant C, Thivolet J, Bussy R.
    Br J Dermatol; 1982 Jul; 107(1):43-51. PubMed ID: 6809029
    [Abstract] [Full Text] [Related]

  • 6. Detection of anti-intercellular cement substance and anti-basement membrane zone antibodies by radioimmunoassay using SCaBER tumour cell line as substrate.
    Bevan HJ, Murahata RI, Ahmed AR.
    Br J Dermatol; 1983 Sep; 109(3):261-5. PubMed ID: 6351893
    [Abstract] [Full Text] [Related]

  • 7. Pemphigus and pemphigoid antibody production by pokeweed mitogen-stimulated peripheral blood mononuclear cell cultures in vitro.
    Fitzmaurice M, Deodhar SD.
    Am J Clin Pathol; 1984 May; 81(5):586-90. PubMed ID: 6372430
    [Abstract] [Full Text] [Related]

  • 8. Pemphigus and pemphigoid antigens are expressed in human amnion epithelium.
    Robinson HN, Anhalt GJ, Patel HP, Takahashi Y, Labib RS, Diaz LA.
    J Invest Dermatol; 1984 Sep; 83(3):234-7. PubMed ID: 6381609
    [Abstract] [Full Text] [Related]

  • 9. Mediators of inflammation in blister fluids from patients with pemphigus vulgaris and bullous pemphigoid.
    Grando SA, Glukhenky BT, Drannik GN, Epshtein EV, Kostromin AP, Korostash TA.
    Arch Dermatol; 1989 Jul; 125(7):925-30. PubMed ID: 2662908
    [Abstract] [Full Text] [Related]

  • 10. Subclass characteristics of IgG autoantibodies in bullous pemphigoid and pemphigus.
    Shirakata Y, Shiraishi S, Sayama K, Miki Y.
    J Dermatol; 1990 Nov; 17(11):661-6. PubMed ID: 2094743
    [Abstract] [Full Text] [Related]

  • 11. Differences in complement-dependent chemotactic activity generated by bullous pemphigoid and epidermolysis bullosa acquisita immune complexes: demonstration by leukocytic attachment and organ culture methods.
    Gammon WR, Inman AO, Wheeler CE.
    J Invest Dermatol; 1984 Jul; 83(1):57-61. PubMed ID: 6376640
    [Abstract] [Full Text] [Related]

  • 12. A case of autoimmune bullous dermatosis with features of pemphigus vulgaris and bullous pemphigoid.
    Kore-eda S, Horiguchi Y, Ohtoshi E, Tanaka T, Fujii K, Okamoto H, Ikai K, Imamura S.
    Am J Dermatopathol; 1995 Oct; 17(5):511-6. PubMed ID: 8599459
    [Abstract] [Full Text] [Related]

  • 13. Lymphotoxin detected in the blister fluid of bullous pemphigoid patients.
    Jeffes EW, Yamamoto RS, Ahmed AR, Granger GA.
    J Clin Immunol; 1984 Jan; 4(1):31-5. PubMed ID: 6365950
    [Abstract] [Full Text] [Related]

  • 14. Presence of interleukin 10 in the serum and blister fluid of patients with pemphigus vulgaris and pemphigoid.
    Bhol KC, Rojas AI, Khan IU, Ahmed AR.
    Cytokine; 2000 Jul; 12(7):1076-83. PubMed ID: 10880254
    [Abstract] [Full Text] [Related]

  • 15. Mechanisms of immunologic injury. Pemphigus and bullous pemphigoid.
    Anhalt GJ, Patel H, Diaz LA.
    Arch Dermatol; 1983 Sep; 119(9):711-4. PubMed ID: 6351756
    [No Abstract] [Full Text] [Related]

  • 16. Localized bullous pemphigoid with negative immunofluorescence.
    Silber JG, Brody N.
    Cutis; 1981 Nov; 28(5):562, 565. PubMed ID: 7030649
    [Abstract] [Full Text] [Related]

  • 17. Functional evidence for complement-activating immune complexes in the skin of patients with bullous pemphigoid.
    Gammon WR, Merritt CC, Lewis DM, Sams WM, Wheeler CE, Carlo JR.
    J Invest Dermatol; 1982 Jan; 78(1):52-7. PubMed ID: 7033396
    [Abstract] [Full Text] [Related]

  • 18. Immunofluorescence studies of pemphigus and pemphigoid in Singapore.
    Tan T, Ratnam KV.
    Ann Acad Med Singap; 1983 Jan; 12(1):13-8. PubMed ID: 6344738
    [Abstract] [Full Text] [Related]

  • 19. Assessment of skin basement membrane zone antibodies in the urine of patients with acquired subepidermal immunobullous diseases.
    Allen J, Shears E, Powell J, Wojnarowska F.
    Br J Dermatol; 2001 Mar; 144(3):540-5. PubMed ID: 11260011
    [Abstract] [Full Text] [Related]

  • 20. C1q binding substances in pemphigus and bullous pemphigoid. Detection with a [131I] C1q binding assay.
    Tappeiner G, Heine KG, Kahl JC, Jordon RE.
    Clin Exp Immunol; 1977 Apr; 28(1):40-8. PubMed ID: 324678
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.